Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{193057,
        author = {Dr.Sanju Sharma and Dr.Sonu and Dr.Jyotsna Thakur and Dr.Vipin kumar},
        title = {A COMPARATIVE CLINICAL STUDY ON THE EFFICACY OF VAMANA KARMA AND UTTARA BASTI ALONG WITH KANCHANARA GUGGULU AND KHADIRA SARA KASHAYA IN THE MANAGEMENT OF GARBHASHAYA GATA ARBUDA [UTERINE FIBROID]-CLINICAL STUDY},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {9},
        pages = {4038-4048},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=193057},
        abstract = {Background:Uterine fibroid (Garbhashaya Gata Arbuda) is one of the most common benign gynecological disorders affecting reproductive and perimenopausal women. Conventional management primarily includes hormonal therapy and surgical interventions, which may be associated with adverse effects, recurrence, and compromise of fertility. Ayurveda offers a holistic and non-invasive approach through Shodhana and Shamana therapies. Vamana Karma, Uttara Basti, and formulations such as Kanchanara Guggulu and Khadira Sara Kashaya are indicated for Kapha-Meda dominant conditions like Arbuda.
Aim:To evaluate and compare the efficacy of Vamana Karma and Uttara Basti along with Kanchanara Guggulu and Khadira Sara Kashaya in the management of Garbhashaya Gata Arbuda (uterine fibroid).
Methods:A randomized, open-label, comparative clinical study was conducted on 40 patients diagnosed with uterine fibroid. Group A received Vamana Karma followed by oral administration of Kanchanara Guggulu and Khadira Sara Kashaya for 60 days. Group B received Uttara Basti with Kshara Taila followed by the same oral medications. Assessment was done using subjective parameters and objective measures such as ultrasonography (USG), PBLAC score, and laboratory investigations. Statistical analysis was carried out using Wilcoxon and Mann–Whitney U tests.
Results:Both groups showed statistically significant improvement in menstrual abnormalities, pain, pressure symptoms, PBLAC score, and hemoglobin levels. Group A demonstrated better improvement in menstrual regularity, duration of bleeding, and dysmenorrhea, while Group B showed relatively better relief in pressure symptoms. Reduction in fibroid size was mild and statistically non-significant in both groups. Inter-group comparison revealed no significant difference, indicating comparable therapeutic efficacy.
Conclusion:Vamana Karma and Uttara Basti, when combined with Kanchanara Guggulu and Khadira Sara Kashaya, are effective, safe, and fertility-preserving Ayurvedic modalities for the management of uterine fibroids. Though fibroid size reduction was minimal, significant symptomatic relief was achieved in both groups.},
        keywords = {Garbhashaya Gata Arbuda, Uterine Fibroid, Vamana Karma, Uttara Basti, Kanchanara Guggulu, Khadira Sara Kashaya, Ayurveda, Clinical Trial.},
        month = {February},
        }